← Leaderboards
Norman Kneteman
$54,291,671
Attributed
$54,291,671
Total exposure
34
Grants
34
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.7M · FY2007–19$50M$37.5M$25M$12.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$54,291,671 · 34
By mechanism
N01$54,291,671 · 34
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Contracts”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,154,975,474
- Leonard Freedman · Leidos Biomedical Research, Inc.$811,365,654
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ContractsCommunicable DiseasesServicesProgramsNational Institute Of Allergy And Infectious DiseasePre-ClinicalAnimal ModelStandardizationTherapeutic DevelopmentEfficacy TestingMaintenancePathogenVaccinesIn Vitro TestingResearch InfrastructureToxicologyVirus DevelopmentCell LineViralNovel VaccinesProduct DevelopmentEmerging Communicable DiseasesBioterrorismDrug Resistance
Grant awards (110)
Task X6: Evaluation of a Leishmania Vaccine$7,172
N01 · FY2019 · AI · contact PI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C$1,359,759
N01 · FY2014 · AI · contact PI
Task X3: Evaluation of Clinical Samples from Influenza Clinical Trials$3,299,568
N01 · FY2013 · AI · contact PI
Task X8: Efficacy Testing of Filovirus Vaccines in Non-Human Primates$2,185,568
N01 · FY2013 · AI · contact PI
Task X8: Efficacy Testing of Filovirus Vaccines in Non-Human Primates$2,185,567
N01 · FY2013 · AI · contact PI
Task 4: The Interventional Agent Development Services program$1,632,116
N01 · FY2013 · AI · contact PI
Task D03 Schistosomiasis Parasites, Reagents and Assays$1,565,946
N01 · FY2013 · AI · contact PI
Task X2: Evaluation of Anthrax Vaccines (AVA)$1,520,428
N01 · FY2013 · AI · contact PI
Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases$1,463,441
N01 · FY2013 · AI · contact PI
Task X 4: Assessment of Simple Adjuvants to Enhance Anthrax Vaccines$1,404,153
N01 · FY2013 · AI · contact PI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C$1,325,700
N01 · FY2013 · AI · contact PI
Task A12: SMALL ANIMAL MODELS FOR MYCOBACTERIA VACCINE TESTING$1,219,723
N01 · FY2013 · AI · contact PI
Task A21: Small Animal Models for Biodefense Viruses$1,204,827
N01 · FY2013 · AI · contact PI
Inner City Asthma Consortium Statistical and Clinical Coordinating Center$1,185,660
N01 · FY2013 · AI · contact PI
Task 4: The Interventional Agent Development Services program$1,052,978
N01 · FY2013 · AI · contact PI
Task 4: The Interventional Agent Development Services program$1,052,978
N01 · FY2013 · AI · contact PI
Task 4: The Interventional Agent Development Services program$1,052,978
N01 · FY2013 · AI · contact PI
Task 4: The Interventional Agent Development Services program$1,000,329
N01 · FY2013 · AI · contact PI
Task A4: TB Early stage animal testing of mycobacterial Interventions$987,958
N01 · FY2013 · AI · contact PI
Task Order 3: Interventional Agent Development Services Program$967,006
N01 · FY2013 · AI · contact PI
Task Order 9 Master Cell Bank for Chlamydia Trachoma Vaccine$956,026
N01 · FY2013 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$905,560
N01 · FY2013 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$857,280
N01 · FY2013 · AI · contact PI
Task 6: Technical Support for Tuberculosis Therapeutics$793,906
N01 · FY2013 · AI · contact PI
Task 4: The Interventional Agent Development Services program$789,734
N01 · FY2013 · AI · contact PI
Task 4: The Interventional Agent Development Services program$789,733
N01 · FY2013 · AI · contact PI
Task A51:PNEUMOCYSTIS PROOF-OF-CONCEPT TESTING OF THERAPEUTICS$789,328
N01 · FY2013 · AI · contact PI
Task 4: The Interventional Agent Development Services program$701,986
N01 · FY2013 · AI · contact PI
task 4: The Interventional Agent Development Services program$701,985
N01 · FY2013 · AI · contact PI
Task B12: Comprehensive Virology Panel$656,876
N01 · FY2013 · AI · contact PI
Task A01: Mouse and Guinea Pig Models for Herpesviruses$638,836
N01 · FY2013 · AI · contact PI
Task A01 Mouse and Guinea Pig Models for Herpesviruses$630,035
N01 · FY2013 · AI · contact PI
Task A09 COTTON RAT MODEL FOR RSV AND OTHER RELATED PARAMYXOVIRUSES$623,396
N01 · FY2013 · AI · contact PI
Task A57:MOUSE MODEL FOR EVALUATION OF COUNTERMEASURES AGAINST MERS$621,632
N01 · FY2013 · AI · contact PI
Task B12: Comprehensive Virology Panel$586,500
N01 · FY2013 · AI · contact PI
Task B12: Comprehensive Virology Panel$554,675
N01 · FY2013 · AI · contact PI
Task A15: Mouse Models for Evaluation of Influenza Vaccines and Adjuvants$552,993
N01 · FY2013 · AI · contact PI
Task A01: Mouse and Guinea Pig Models for Herpesviruses$541,468
N01 · FY2013 · AI · contact PI
Task X6: Evaluation of a Leishmania Vaccine$537,975
N01 · FY2013 · AI · contact PI
Task Order 1: The Interventional Agent Development Services Program$497,009
N01 · FY2013 · AI · contact PI
Task A08: In Vitro Characterization Of Antimicrobial Activity$497,000
N01 · FY2013 · AI · contact PI
Task Order 2: The Interventional Agent Development Services Program$451,698
N01 · FY2013 · AI · contact PI
Task B12: Comprehensive Virology Panel$437,916
N01 · FY2013 · AI · contact PI
Task Order 2: The Interventional Agent Development Services Program$402,866
N01 · FY2013 · AI · contact PI
Task A08 Rabbit and Mouse Models for Papillomaviruses$395,960
N01 · FY2013 · AI · contact PI
VACCINE TREATMENT EVALUATION UNITS (VTEUS)$390,743
N01 · FY2013 · AI · contact PI
Task A19 HUMAN HEPATITIS B VIRUS (HBV) MOUSE MODELS FOR TESTING HBV THERAPEUTICS$371,637
N01 · FY2013 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS (VTEUS)$371,344
N01 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units (VTEUs)$349,613
N01 · FY2013 · AI · contact PI
Task D06: Woodchuck Animal Model for Testing HBV Therapeutics$339,270
N01 · FY2013 · AI · contact PI
Task A58: TESTING OF MUTANT MYCOBACTERIA IN SMALL ANIMAL MODELS$312,973
N01 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units (VTEUs)$297,960
N01 · FY2013 · AI · contact PI
Task Order 2: Interventional Agent Development Services Program$292,993
N01 · FY2013 · AI · contact PI
Task A56:Mouse model of low-pathogenic seasonal and pandemic influenza$284,000
N01 · FY2013 · AI · contact PI
Task X5: Challenge Biodistribution Study for Malaria Vaccines$248,685
N01 · FY2013 · AI · contact PI
SVEU - Core Activities - Administrative and Technical Support$239,730
N01 · FY2013 · AI · contact PI
Task B12: Comprehensive Virology Panel$235,350
N01 · FY2013 · AI · contact PI
Task A52:Testing Therapeutics for MDR Pseudomonas aeruginosa$213,493
N01 · FY2013 · AI · contact PI
Task A57: MOUSE MODEL FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR MERS$213,390
N01 · FY2013 · AI · contact PI
Task B12: Comprehensive Virology Panel$193,199
N01 · FY2013 · AI · contact PI
SVEU - Maintenance of NHPs$191,821
N01 · FY2013 · AI · contact PI
Task Order 5: The Interventional Agent Development Services Program$176,000
N01 · FY2013 · AI · contact PI
Task 1: Evaluation and Testing Services (ETS) for Vaccines and Other Biologics$172,207
N01 · FY2013 · AI · contact PI
Task Order 3:Interventional Agent Development Services Program$170,648
N01 · FY2013 · AI · contact PI
Task X6 Generation of a Shigella Vaccine$167,808
N01 · FY2013 · AI · contact PI
Manufacture and Characterization Services for Vaccines and Biologics$160,797
N01 · FY2013 · AI · contact PI
Task E2: Central Data Management Center - Maintenance$156,445
N01 · FY2013 · AI · contact PI
Task A56:Mouse model of low-pathogenic seasonal and pandemic influenza$121,633
N01 · FY2013 · AI · contact PI
Task A9: In vitro screening for antibacterial activity$104,809
N01 · FY2013 · AI · contact PI
Task Order 3: Interventional Agent Development Services Program$102,519
N01 · FY2013 · AI · contact PI
Task Order 2: The Interventional Agent Development Services Program$97,664
N01 · FY2013 · AI · contact PI
Task X2: Feasibility and PDP support for Staphylococcal Aureus Vaccines$90,915
N01 · FY2013 · AI · contact PI
Task X2: Feasibility and PDP support for Rickettsia Prowazekii$90,915
N01 · FY2013 · AI · contact PI
Task X2: Feasibility and PDP support for RSV vaccines$90,915
N01 · FY2013 · AI · contact PI
Task Order 3: Interventional Agent Development Services Program$90,217
N01 · FY2013 · AI · contact PI
Task Order 5: The Interventional Agent Development Services Program$89,894
N01 · FY2013 · AI · contact PI
Task Order 5: The Interventional Agent Development Services Program$87,251
N01 · FY2013 · AI · contact PI
Task Order 5: The Interventional Agent Development Services Program$87,251
N01 · FY2013 · AI · contact PI
Task B12: Comprehensive Virology Panel$83,000
N01 · FY2013 · AI · contact PI
Task Order 2: The Interventional Agent Development Services Program$82,404
N01 · FY2013 · AI · contact PI
Task Order 2: The Interventional Agent Development Services Program$73,249
N01 · FY2013 · AI · contact PI
Task Order 2: Interventional Agent Development Services Program$73,248
N01 · FY2013 · AI · contact PI
Task A03: In Vitro Screening for Antifungal Activity$71,661
N01 · FY2013 · AI · contact PI
Task B10: In Vitro Assessments for Respiratory Viruses$70,070
N01 · FY2013 · AI · contact PI
Task Order 3: Interventional Agent Development Services Program$69,715
N01 · FY2013 · AI · contact PI
Task Order 3: Interventional Agent Development Services Program$53,310
N01 · FY2013 · AI · contact PI
Task Order 3: Interventional Agent Development Services Program$53,310
N01 · FY2013 · AI · contact PI
Task Order 2: The Interventional Agent Development Services Program$51,884
N01 · FY2013 · AI · contact PI
Task Order 3: Interventional Agent Development Services Program$41,007
N01 · FY2013 · AI · contact PI
Task B10: In Vitro Assessments for Respiratory Viruses$30,030
N01 · FY2013 · AI · contact PI
Task A42: Ferret Influenza Model for Vaccine Proof of Concept Studies$28,750
N01 · FY2013 · AI · contact PI
Task A07: Neisseria gonorrhoeae MIC testing$27,108
N01 · FY2013 · AI · contact PI
Task B12: Comprehensive Virology Panel$26,150
N01 · FY2013 · AI · contact PI
Task B13: In vitro screening for viral respiratory panel$24,080
N01 · FY2013 · AI · contact PI
Task B14: Papillomavirus secondary Assay$12,178
N01 · FY2013 · AI · contact PI
Task A6: In vitro assessment for antifungal activity$7,212
N01 · FY2013 · AI · contact PI
Animal Models of Infectious Diseases$4,309
N01 · FY2013 · AI · contact PI
Task B13: In vitro screening for viral respiratory panel$4,020
N01 · FY2013 · AI · contact PI
Animal Models of Infectious Diseases$3,621
N01 · FY2013 · AI · contact PI
Animal Models of Infectious Diseases$2,123
N01 · FY2013 · AI · contact PI
Animal Models of Infectious Diseases$2,106
N01 · FY2013 · AI · contact PI
Task B11:Comprehensive Panel for Viruses$1,621
N01 · FY2013 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$1,591
N01 · FY2013 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$969
N01 · FY2013 · AI · contact PI
Animal Models of Infectious Diseases$570
N01 · FY2013 · AI · contact PI
Task B10: In Vitro Assessment for Antimicrobial Activity for Respiratory Viruses$400
N01 · FY2013 · AI · contact PI
Task B11: Comprehensive Panel for Viruses$284
N01 · FY2013 · AI · contact PI
Animal Models for the Prevention and Treatment of Hepatitis C$260,577
N01 · FY2012 · AI · contact PI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C$1,260,145
N01 · FY2011 · AI · contact PI
ANIMAL MODELS FOR THE PREVENTION AND TREATMENT OF HEPATITIS B AND HEPATITIS C$1,680,652
N01 · FY2007 · AI · contact PI